Certain long acting release oral, transdermal or inhaled drug delivery systems may enhance effi cacy through improved pharmacokinetics and increased bioavailability. Additionally, a limited number of these technologies may offer improved safety and convenience, leading to better product compliance and associated benefi ts. Further, certain drug delivery systems may allow for the extension of a product's life-cycle by refreshing the therapy's intellectual property. In addition to improving current therapies, some drug delivery technologies also have the capacity to enable new chemical entities to reach their target markets.

• To review the attributes of drug delivery technologies and consider their impact on the pharmaceutical marketplace as it relates to currently approved products or new chemical entities
• Provide information to the audience on the challenges and opportunities associated with reformulating and delivering therapies via an alternative route of administration
• Discuss benefits for patients, caregivers, health care practitioners and realize the market potential for these enabling technologies